Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma. Issue 5 (15th April 2020) - Ivanov, Vadim; Farnault, Laure; Mercier, Cedric; Colavolpe, Cecile; Venton, Geoffroy; Colle, Julien; Lepidi, Hubert; Arnoux, Isabelle; Nicolino-Brunet, Corinne; Berda-Haddad, Yael; Fanciullino, Raphaelle; Ivanov, Gleb; et al.